{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:53Z","timestamp":1792784993905,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Heart and Lung Foundation","award":["20210062"],"award-info":[{"award-number":["20210062"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20210543"],"award-info":[{"award-number":["20210543"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-06531"],"award-info":[{"award-number":["2021-06531"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dysautonomia International"},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["964100"],"award-info":[{"award-number":["964100"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-acute COVID-19 (PACS) are associated with cardiovascular dysfunction, especially postural orthostatic tachycardia syndrome (POTS). Patients with PACS, both in the absence or presence of POTS, exhibit a wide range of persisting symptoms long after the acute infection. Some of these symptoms may stem from alterations in cardiovascular homeostasis, but the exact mechanisms are poorly understood. The aim of this study was to provide a broad molecular characterization of patients with PACS with (PACS\u2009+\u2009POTS) and without (PACS-POTS) POTS compared to healthy subjects, including a broad proteomic characterization with a focus on plasma cardiometabolic proteins, quantification of cytokines\/chemokines and determination of plasma sphingolipid levels. Twenty-one healthy subjects without a prior COVID-19 infection (mean age 43\u00a0years, 95% females), 20 non-hospitalized patients with PACS\u2009+\u2009POTS (mean age 39\u00a0years, 95% females) and 22 non-hospitalized patients with PACS-POTS (mean age 44\u00a0years, 100% females) were studied. PACS patients were non-hospitalized and recruited \u224818\u00a0months after the acute infection. Cardiometabolic proteomic analyses revealed a dysregulation of \u2248200 out of 700 analyzed proteins in both PACS groups vs. healthy subjects with the majority (&gt;\u200990%) being upregulated. There was a large overlap (&gt;\u200990%) with no major differences between the PACS groups. Gene ontology enrichment analysis revealed alterations in hemostasis\/coagulation, metabolism, immune responses, and angiogenesis in PACS vs. healthy controls. Furthermore, 11 out of 33 cytokines\/chemokines were significantly upregulated both in PACS\u2009+\u2009POTS and PACS-POTS vs. healthy controls and none of the cytokines were downregulated. There were no differences in between the PACS groups in the cytokine levels. Lastly, 16 and 19 out of 88 sphingolipids were significantly dysregulated in PACS\u2009+\u2009POTS and PACS-POTS, respectively, compared to controls with no differences between the groups. Collectively, these observations suggest a clear and distinct dysregulation in the proteome, cytokines\/chemokines, and sphingolipid levels in PACS patients compared to healthy subjects without any clear signature associated with POTS. This enhances our understanding and might pave the way for future experimental and clinical investigations to elucidate and\/or target resolution of inflammation and micro-clots and restore the hemostasis and immunity in PACS.<\/jats:p>","DOI":"10.1038\/s41598-023-47539-1","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:01:58Z","timestamp":1700373718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study"],"prefix":"10.1038","volume":"13","author":[{"given":"Ali","family":"Mahdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Fredengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Fedorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Nygren-Bonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Runold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannike","family":"Nickander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Checa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyew","family":"Desta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pernow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"St\u00e5hlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,19]]},"reference":[{"issue":"4","key":"47539_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27(4), 601\u2013615 (2021).","journal-title":"Nat. Med."},{"issue":"11","key":"47539_CR2","first-page":"156","volume":"8","author":"G Bisaccia","year":"2021","unstructured":"Bisaccia, G. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know?. J. Cardiovasc. Dev. Dis. 8(11), 156 (2021).","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"10350","key":"47539_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering, A. V. et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet 400(10350), 452\u2013461 (2022).","journal-title":"Lancet"},{"issue":"19","key":"47539_CR4","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.2021.5612","volume":"325","author":"S Havervall","year":"2021","unstructured":"Havervall, S. et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA 325(19), 2015\u20132016 (2021).","journal-title":"JAMA"},{"issue":"4","key":"47539_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaccas.2021.01.009","volume":"3","author":"M Johansson","year":"2021","unstructured":"Johansson, M. et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: The Swedish experience. JACC Case Rep. 3(4), 573\u2013580 (2021).","journal-title":"JACC Case Rep."},{"key":"47539_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.08.085","author":"R Hira","year":"2022","unstructured":"Hira, R. et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can. J. Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2022.08.085 (2022).","journal-title":"Can. J. Cardiol."},{"key":"47539_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.123.011881","author":"A Mahdi","year":"2023","unstructured":"Mahdi, A. et al. Microvasular dysfunction and reduced cardiac stress reactivity in postural orthostatic tachycardia associated with postacute COVID-19. Circ. Arrhythm. Electrophysiol. https:\/\/doi.org\/10.1161\/CIRCEP.123.011881 (2023).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"3","key":"47539_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E. et al. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21(3), 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"47539_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/ene.15714","volume":"30","author":"D Reis Carneiro","year":"2023","unstructured":"Reis Carneiro, D. et al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection\u2014A systematic review. Eur. J. Neurol. 30(5), 1528\u20131539 (2023).","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"47539_CR10","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22(4), e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"47539_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/joim.12852","volume":"285","author":"A Fedorowski","year":"2019","unstructured":"Fedorowski, A. Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. J. Intern. Med. 285(4), 352\u2013366 (2019).","journal-title":"J. Intern. Med."},{"issue":"6","key":"47539_CR12","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","volume":"12","author":"RS Sheldon","year":"2015","unstructured":"Sheldon, R. S. et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 12(6), e41-63 (2015).","journal-title":"Heart Rhythm"},{"issue":"5","key":"47539_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/healthcare9050575","volume":"9","author":"G Orru","year":"2021","unstructured":"Orru, G. et al. Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel) 9(5), 575 (2021).","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"47539_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/joim.13566","volume":"293","author":"JM Spahic","year":"2023","unstructured":"Spahic, J. M. et al. Malmo POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome. J. Intern. Med. 293(1), 91\u201399 (2023).","journal-title":"J. Intern. Med."},{"issue":"4","key":"47539_CR15","doi-asserted-by":"publisher","first-page":"M110.004978","DOI":"10.1074\/mcp.M110.004978","volume":"10","author":"M Lundberg","year":"2011","unstructured":"Lundberg, M. et al. Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material. Mol. Cell. Proteomics 10(4), M110.004978 (2011).","journal-title":"Mol. Cell. Proteomics"},{"issue":"7","key":"47539_CR16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"47539_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","volume":"18","author":"RH Choi","year":"2021","unstructured":"Choi, R. H. et al. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat. Rev. Cardiol. 18(10), 701\u2013711 (2021).","journal-title":"Nat. Rev. Cardiol."},{"issue":"17","key":"47539_CR18","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.CIR.0000035650.05921.50","volume":"106","author":"H Li","year":"2002","unstructured":"Li, H. et al. Dual effect of ceramide on human endothelial cells: Induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 106(17), 2250\u20132256 (2002).","journal-title":"Circulation"},{"issue":"2","key":"47539_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","volume":"70","author":"A Cantalupo","year":"2017","unstructured":"Cantalupo, A. et al. S1PR1 (sphingosine-1-phosphate receptor 1) signaling regulates blood flow and pressure. Hypertension 70(2), 426\u2013434 (2017).","journal-title":"Hypertension"},{"issue":"2","key":"47539_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/cvr\/cvw256","volume":"113","author":"A Meissner","year":"2017","unstructured":"Meissner, A. et al. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of angiotensin II-induced hypertension. Cardiovasc. Res. 113(2), 123\u2013133 (2017).","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"47539_CR21","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.3390\/ijms23052414","volume":"23","author":"M Costanzo","year":"2022","unstructured":"Costanzo, M. et al. COVIDomics: The proteomic and metabolomic signatures of COVID-19. Int. J. Mol. Sci. 23(5), 2414 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"47539_CR22","doi-asserted-by":"publisher","first-page":"812431","DOI":"10.3389\/fimmu.2022.812431","volume":"13","author":"S She","year":"2022","unstructured":"She, S. et al. Functional roles of chemokine receptor CCR2 and its ligands in liver disease. Front. Immunol. 13, 812431 (2022).","journal-title":"Front. Immunol."},{"issue":"12","key":"47539_CR23","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","volume":"187","author":"KE Cole","year":"1998","unstructured":"Cole, K. E. et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187(12), 2009\u20132021 (1998).","journal-title":"J. Exp. Med."},{"issue":"3","key":"47539_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacbts.2021.12.003","volume":"7","author":"A Mahdi","year":"2022","unstructured":"Mahdi, A. et al. Erythrocytes induce vascular dysfunction in COVID-19. JACC Basic Transl. Sci. 7(3), 193\u2013204 (2022).","journal-title":"JACC Basic Transl. Sci."},{"issue":"1","key":"47539_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","volume":"20","author":"E Pretorius","year":"2021","unstructured":"Pretorius, E. et al. Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20(1), 172 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"22","key":"47539_CR26","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.3390\/jcm10225381","volume":"10","author":"GJ Laubscher","year":"2021","unstructured":"Laubscher, G. J. et al. TEG((R)), microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J. Clin. Med. 10(22), 5381 (2021).","journal-title":"J. Clin. Med."},{"issue":"1","key":"47539_CR27","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1038\/s41598-022-24729-x","volume":"12","author":"M Johansson","year":"2022","unstructured":"Johansson, M. et al. Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways. Sci. Rep. 12(1), 20051 (2022).","journal-title":"Sci. Rep."},{"issue":"6","key":"47539_CR28","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte, R. S., Chen, D. S. & Ferrara, N. VEGF in signaling and disease: Beyond discovery and development. Cell 176(6), 1248\u20131264 (2019).","journal-title":"Cell"},{"issue":"6","key":"47539_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ijc.21479","volume":"117","author":"H van Cruijsen","year":"2005","unstructured":"van Cruijsen, H., Giaccone, G. & Hoekman, K. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. Int. J. Cancer 117(6), 883\u2013888 (2005).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"47539_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.smim.2014.02.006","volume":"26","author":"LC Burkly","year":"2014","unstructured":"Burkly, L. C. TWEAK\/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities. Semin. Immunol. 26(3), 229\u2013236 (2014).","journal-title":"Semin. Immunol."},{"issue":"3","key":"47539_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1708538120959972","volume":"29","author":"S Xue","year":"2021","unstructured":"Xue, S. et al. C-C Motif chemokine 8 promotes angiogenesis in vascular endothelial cells. Vascular 29(3), 429\u2013441 (2021).","journal-title":"Vascular"},{"issue":"1","key":"47539_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1096\/fj.08-113860","volume":"23","author":"J Zhang","year":"2009","unstructured":"Zhang, J. et al. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J. 23(1), 153\u2013163 (2009).","journal-title":"FASEB J."},{"issue":"2","key":"47539_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.atherosclerosis.2015.10.022","volume":"243","author":"JM Cheng","year":"2015","unstructured":"Cheng, J. M. et al. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study. Atherosclerosis 243(2), 560\u2013566 (2015).","journal-title":"Atherosclerosis"},{"issue":"6","key":"47539_CR34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","volume":"36","author":"A Edsfeldt","year":"2016","unstructured":"Edsfeldt, A. et al. Sphingolipids contribute to human atherosclerotic plaque inflammation. Arterioscler. Thromb. Vasc. Biol. 36(6), 1132\u20131140 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"25","key":"47539_CR35","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen, R. et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur. Heart J. 37(25), 1967\u20131976 (2016).","journal-title":"Eur. Heart J."},{"key":"47539_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fendo.2020.00491","volume":"11","author":"S Tan-Chen","year":"2020","unstructured":"Tan-Chen, S. et al. Sphingolipid metabolism and signaling in skeletal muscle: From physiology to physiopathology. Front. Endocrinol. (Lausanne) 11, 491 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"47539_CR37","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","volume":"12","author":"SE Chang","year":"2021","unstructured":"Chang, S. E. et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 12(1), 5417 (2021).","journal-title":"Nat. Commun."},{"issue":"12","key":"47539_CR38","doi-asserted-by":"publisher","first-page":"e0308","DOI":"10.1097\/CCE.0000000000000308","volume":"2","author":"J van der Linden","year":"2020","unstructured":"van der Linden, J. et al. Thromboembolism, hypercoagulopathy, and antiphospholipid antibodies in critically ill coronavirus disease 2019 patients: A before and after study of enhanced anticoagulation. Crit. Care Explor. 2(12), e0308 (2020).","journal-title":"Crit. Care Explor."},{"issue":"7","key":"47539_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/europace\/euw154","volume":"19","author":"A Fedorowski","year":"2017","unstructured":"Fedorowski, A. et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace 19(7), 1211\u20131219 (2017).","journal-title":"Europace"},{"issue":"15","key":"47539_CR40","doi-asserted-by":"publisher","first-page":"e015989","DOI":"10.1161\/JAHA.120.015989","volume":"9","author":"I Kharraziha","year":"2020","unstructured":"Kharraziha, I. et al. Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J. Am. Heart Assoc. 9(15), e015989 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"47539_CR41","doi-asserted-by":"publisher","first-page":"866113","DOI":"10.3389\/fcvm.2022.866113","volume":"9","author":"S Charfeddine","year":"2022","unstructured":"Charfeddine, S. et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 9, 866113 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"47539_CR42","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1055\/a-1414-5216","volume":"121","author":"AJ Gonzalez-Ochoa","year":"2021","unstructured":"Gonzalez-Ochoa, A. J. et al. Sulodexide in the treatment of patients with early stages of COVID-19: A randomized controlled trial. Thromb. Haemost. 121(7), 944\u2013954 (2021).","journal-title":"Thromb. Haemost."},{"issue":"4","key":"47539_CR43","doi-asserted-by":"publisher","first-page":"611e9","DOI":"10.1016\/j.cmi.2021.11.002","volume":"28","author":"F Bai","year":"2022","unstructured":"Bai, F. et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 28(4), 611e9-611e16 (2022).","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47539-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T09:25:21Z","timestamp":1700385921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47539-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,19]]},"assertion":[{"value":"15 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20230"}}